Covid, from Aifa ok at the third dose. Hope: we start with the most fragile

Covid, from Aifa ok at the third dose. Hope: we start with the most fragile
Covid, from Aifa ok at the third dose. Hope: we start with the most fragile
  • Thursday 09 September 2021

«We will start with the most fragile ones that after two doses do not have the necessary protection. There will then be a circular from the ministry on the matter ». Health Minister Roberto Speranza says this after Aifa gave the ok to the third dose.

The Board of Directors of the Italian Medicines Agency (Aifa), called urgently, “unanimously approved the use of an additional dose of mRNA vaccine (third dose). The measure concerns subjects with severe immunosuppression, in accordance with the assessment of the treating physician, such as for example transplant recipients, oncologists, dialysis patients as well as the elderly (≥ 80 years) and hospitalized in RSA “. This was announced by Aifa in a press release, with the Minister of Health Roberto Speranza reporting: «We will start with the most fragile ones that after two doses do not have the necessary protection. After the green light of Aifa, there will be a circular from the Ministry of Health that will identify the categories, “he said.

The third booster dose of the anti-Covid vaccine should be administered, according to what is learned, “at least after 28 days” from the second dose for immunosuppressed and transplant recipients. The recall should instead be made “at least after six months” for the other categories indicated, that is the elderly, guests of the Rsa and health personnel at risk.

The additional vaccination provided for in the resolution, explains Aifa, “will be made available by inserting the Cominarty and Spikevax vaccines in the list referred to in Law 648/96 with expenditure to be paid by a special fund of the Ministry of Health dedicated to the purchase of Covid drugs and vaccines, in analogy to what has already happened for the emergency provision for the use of anti-SARS-CoV-2 monoclonal antibodies ». The provision, specifies AIFA, “does not include the general population pending Ema to evaluate the data provided by the manufacturers of the aforementioned vaccines”.

“The extension of this measure to the national level – concludes Aifa – assumed in advance of the Ema position, is configured as an important public health act aimed at protecting the population most exposed to the risk of developing serious forms of Covid 19”.

“After the first band we will start with the first ones who have been vaccinated: making Rsa safe is a priority and then we must safeguard the over-80s and health personnel. We reconfirm that we have no difficulty with the availability of doses. We can guarantee the third dose »said Speranza.


© REPRODUCTION RESERVED

PREV Pippo Franco: "I think like Montagnier on the vaccine, I have the green pass and more than that I don’t … – La7 News
NEXT Coronavirus in Piedmont, the bulletin of September 18: 237 cases with over 36 thousand swabs, 4 deaths